Showing posts with label GlaxoSmithKline. Show all posts
Showing posts with label GlaxoSmithKline. Show all posts

Wednesday, December 18, 2013

Leading Drug Company to Quit Paying Doctors for Promotional Talks

GlaxoSmithKline, which makes Advair for asthma, Lovaza for high triglyceride levels and the diabetes drug Avandia, is under pressure facing all drug companies for greater transparency in payments to doctors, a provision of Obamacare
Scientific American
By Charles Ornstein and ProPublica
In a major departure from industry practice, GlaxoSmithKline, the sixth-largest global drug maker, announced Tuesday that it will no longer hire doctors to promote its drugs.

The company also will stop tying compensation for sales representatives to the number of prescriptions written for drugs they market. The changes will be made worldwide over the next two years.